Delivering Crocetin across the Blood-Brain Barrier by Using γ-Cyclodextrin to Treat Alzheimer’s Disease

Crocetin (CRT) has shown various neuroprotective effects such as antioxidant activities and the inhibition of amyloid β fibril formation, and thus is a potential therapeutic candidate for Alzheimer’s disease (AD). However, poor water solubility and bioavailability are the major obstacles in formulat...

Descripción completa

Detalles Bibliográficos
Autores principales: Wong, Ka Hong, Xie, Yuning, Huang, Xiao, Kadota, Kazunori, Yao, Xin-Sheng, Yu, Yang, Chen, Xiaoyu, Lu, Aiping, Yang, Zhijun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7046745/
https://www.ncbi.nlm.nih.gov/pubmed/32107408
http://dx.doi.org/10.1038/s41598-020-60293-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7046745/
https://www.ncbi.nlm.nih.gov/pubmed/32107408
http://dx.doi.org/10.1038/s41598-020-60293-y

Ejemplares similares